Provider
P45-17 New Drug-Related Prior Authorization and Quantity Limit Criteria: Concurrent Opioids with Buprenorphine
Program effective Date: Aug 14, 2017
Search Results
Displaying 3221 - 3230 of 3887 results
Provider
P13-17 Added Reimbursement Policy for General Coding: Total Parenteral Nutrition Billing
Program effective Date: Apr 07, 2017
Provider
P42-17 Addition of Drugs to Self-Administered Oncology Prior Authorization with Quantity Limit Program
Program effective Date: Aug 03, 2017
Provider
P77-17 Medicare Advantage Process for NOMNC Letter
Program effective Date: Dec 12, 2017
Provider
P44-17 New Drug-Related Prior Authorization and Quantity Limit Criteria: Opioid, Buprenorphine Concurrent Therapy
Program effective Date: Aug 14, 2017
Provider
P16-17 Changes in Medical Policy IV-107 Hip Arthroplasty (Hip Replacement) and Hip Resurfacing
Program effective Date: Apr 28, 2017
Provider
P34-18 Clarification to MAPD PA Requirements for Hereditary Angioedema (HAE) Medical Drugs
Program effective Date: Aug 01, 2018
Provider
P35-17 Addition of Drug to the Substance Reduction Therapy Prior Authorization with Quantity Limit Program
Program effective Date: Jun 13, 2017
Provider
P49-17 Two New Medicare Advantage Prescription Drug Products in 2018
Program effective Date: Sep 25, 2017
Provider
P11-17 Pre-Admission Notification Requirement for Admissions Effective June 1, 2017
Program effective Date: Apr 04, 2017